CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Sotagliflozin, a Dual SGLT1 and SGLT2 Inhibitor, as Adjunct Therapy to Insulin in Type 1 Diabetes
Authors
Phillip Banks
Bruce W. Bode
+10 more
John B. Buse
William T. Cefalu
Satish K. Garg
Rubina Heptulla
Pablo Lapuerta
Marc Rendell
Julio Rosenstock
Arthur T. Sands
Paul Strumph
Brian P. Zambrowicz
Publication date
1 January 2015
Publisher
Doi
Cite
View
on
PubMed
Abstract
To assess the safety and efficacy of dual sodium–glucose cotransporter (SGLT) 1 and SGLT2 inhibition with sotagliflozin as adjunct therapy to insulin in type 1 diabetes
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Carolina Digital Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
cdr.lib.unc.edu:2z10wx15s
Last time updated on 24/11/2020
